Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Psychiatr Serv ; 73(7): 787-800, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-34875848

RESUMO

OBJECTIVE: The authors conducted a systematic review of studies evaluating vocational interventions for young people with psychiatric conditions to determine the extent to which services were adapted for young people and whether services promoted gains in postsecondary education and employment. METHODS: Five databases (PubMed, PsycINFO, Web of Science, Academic Search Premier, and ERIC) were searched. Sources eligible for inclusion were controlled studies published between 2000 and mid-2020 that evaluated a vocational intervention and examined postsecondary educational or employment outcomes for youths or young adults (ages 14-35 years) with psychiatric conditions. RESULTS: Ten studies met the inclusion criteria. Several of the studies evaluated services that were adapted for young people, including through the incorporation of educational supports. The most consistent finding was that services based on the individual placement and support (IPS) model improved employment outcomes more effectively than did comparison approaches and treatment as usual. Fewer studies assessed educational outcomes, and they yielded mixed results; however, recent findings from a controlled trial indicate that an enhanced IPS intervention that included well-specified supported education and skills training led to significantly superior outcomes in both education and employment. CONCLUSIONS: These results provide support for the efficacy of IPS-based services to improve employment outcomes among young people with psychiatric conditions and suggest that adapting IPS to include comprehensive educational supports and skills training may be important for efforts to improve postsecondary educational outcomes. Additional well-controlled intervention studies that examine educational and longer-term outcomes should further inform the development and delivery of vocational services for this population.


Assuntos
Readaptação ao Emprego , Transtornos Mentais , Adolescente , Adulto , Escolaridade , Humanos , Transtornos Mentais/terapia , Reabilitação Vocacional/métodos , Adulto Jovem
2.
Psychiatr Rehabil J ; 40(1): 103-107, 2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-28368183

RESUMO

OBJECTIVE: Given the poor educational outcomes associated with psychiatric conditions, we developed Focused Academic Strength Training (FAST), a 12-week strategy-focused cognitive remediation intervention designed to improve academic functioning among college students with psychiatric conditions. Here we report initial results from a randomized controlled trial of FAST. METHOD: Seventy-two college students with mood, anxiety, and/or psychotic disorders were randomized to receive FAST or services as usual and were assessed at baseline and 4 months (posttreatment). RESULTS: Repeated-measures analyses of variance indicated FAST-associated improvements in self-reported cognitive strategy use (p < .001), self-efficacy (p = .001), and academic difficulties (p = .025). There were no significant treatment-related improvements in neuropsychological performance. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: FAST may lead to an increase in self-efficacy and cognitive strategy use, as well as a reduction in academic difficulties among students with psychiatric conditions. Future analyses with follow-up data through 12 months will address the potential of FAST to improve academic functioning among this population. (PsycINFO Database Record


Assuntos
Desempenho Acadêmico , Transtornos de Ansiedade/reabilitação , Remediação Cognitiva/métodos , Transtornos do Humor/reabilitação , Transtornos Psicóticos/reabilitação , Estudantes , Adolescente , Adulto , Função Executiva/fisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação de Programas e Projetos de Saúde , Autoeficácia , Universidades , Adulto Jovem
4.
Ann Pharmacother ; 40(11): 1939-45, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17018688

RESUMO

BACKGROUND: Multidrug-resistant Acinetobacter baumannii (MDR-Ab) has emerged as an increasingly problematic cause of hospital-acquired infections in the intensive care unit (ICU). MDR-Ab is resistant to most standard antimicrobials but often retains susceptibility to polymyxin B and doxycycline. OBJECTIVE: To evaluate the efficacy and toxicity of polymyxin B and doxycycline in the treatment of MDR-Ab infections. METHODS: A retrospective chart review was conducted between March 2002 and May 2005 in patients who received doxycycline or polymyxin B for treatment of MDR-Ab infections in ICUs within Grady Memorial Hospital, Atlanta, GA. RESULTS: Thirty-seven patients with MDR-Ab infections were treated with polymyxin B or doxycycline. Median age was 41 years and median ICU length of stay was 18 days prior to acquisition of MDR-Ab. Clinical cure was observed in 22 of 29 (76%) evaluable patients treated with polymyxin B and 2 of 4 (50%) patients treated with doxycycline. In patients with follow-up cultures, microbiological cure was observed in 17 of 21 (81%) patients treated with polymyxin B and 2 of 3 (67%) patients treated with doxycycline. Nephrotoxicity developed in 21% (7 of 33) of patients who received polymyxin B. Neurotoxicity was observed in 2 (6%) patients who received polymyxin B. No adverse reactions were observed with doxycycline. Overall, crude mortality was 27% (9 of 33) and 75% (3 of 4) among those who received polymyxin B and doxycycline, respectively. Three (9%) deaths were attributed to polymyxin B treatment failure, and no deaths were attributed to doxycycline treatment failure. CONCLUSIONS: Polymyxin B was effectively used to treat a substantial proportion of critically ill patients with MDR-Ab infection and was associated with a similar rate of nephrotoxicity as previously reported. Doxycycline monotherapy was used in a limited number of patients for the treatment of MDR-Ab; further evaluation of its efficacy in larger numbers of patients is warranted.


Assuntos
Infecções por Acinetobacter/tratamento farmacológico , Acinetobacter baumannii , Infecção Hospitalar/tratamento farmacológico , Doxiciclina/administração & dosagem , Unidades de Terapia Intensiva/estatística & dados numéricos , Polimixina B/administração & dosagem , Infecções por Acinetobacter/epidemiologia , Infecções por Acinetobacter/mortalidade , Acinetobacter baumannii/efeitos dos fármacos , Adolescente , Adulto , Idoso , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/mortalidade , Farmacorresistência Bacteriana Múltipla , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polimixina B/efeitos adversos , Estudos Retrospectivos
6.
Behav Neurosci ; 118(6): 1240-52, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15598133

RESUMO

In operant tasks, control rats maintain high response rates under positive contingencies, when the probability of reinforcement is greater following a response (contingent reinforcement) than during the absence of that response. However, as contingencies approach zero, response rates decrease. In this experiment, under immediate contingent reinforcement, rats with medial septal lesions reduced their response rates, just like controls, when contingencies were shifted from positive toward zero. However, the septal rats were less sensitive to this contingency shift, compared with controls, when there was a 5-s delay between lever presses and contingent reinforcements. This lesion effect appeared to be due to a failure of voluntary response memory, which impaired sensitivity to operant contingencies when there was a delay between action and outcome.


Assuntos
Associação , Condicionamento Operante/fisiologia , Aprendizagem por Discriminação/fisiologia , Reforço Psicológico , Septo do Cérebro/fisiologia , Animais , Comportamento Animal , Encefalopatias/fisiopatologia , Eletrólise/métodos , Masculino , Ratos , Ratos Long-Evans , Tempo de Reação/fisiologia , Esquema de Reforço , Septo do Cérebro/anatomia & histologia , Septo do Cérebro/lesões , Estatísticas não Paramétricas
7.
Ann Pharmacother ; 38(1): 142-5, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14742808

RESUMO

OBJECTIVE: To evaluate the safety and cardiovascular benefits of beta-blocker therapy in patients with chronic obstructive pulmonary disease (COPD). DATA SOURCES: Clinical literature was accessed through MEDLINE (1966-February 2003). Key search terms included chronic obstructive pulmonary disease and adrenergic beta-antagonists. DATA SYNTHESIS: beta-Blockers are often avoided in patients with COPD because of fear of bronchoconstriction, despite the known cardiovascular mortality benefits. A review of studies evaluating the use of beta-blockers in COPD was undertaken. CONCLUSIONS: The literature supports the safety and mortality benefits of using beta-blockers in COPD. Patients with mild to moderate COPD should receive cardioselective beta-blocker therapy when a strong indication exists.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Revisão de Uso de Medicamentos , Humanos , Medição de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...